Front Office Sports on MSN
Serena Williams’s GLP-1 Ads Will Air During Her Return to Tennis This Week
Williams is returning to competitive tennis for the first time since 2022.
With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results